Deutsche Bank set a €66.00 ($78.57) price objective on Gerresheimer (ETR:GXI) in a research note issued to investors on Monday morning. The brokerage currently has a neutral rating on the stock.

A number of other brokerages have also recently commented on GXI. Commerzbank set a €77.00 ($91.67) target price on shares of Gerresheimer and gave the company a buy rating in a report on Monday, October 23rd. Hauck & Aufhaeuser set a €55.00 ($65.48) target price on shares of Gerresheimer and gave the company a sell rating in a report on Wednesday, January 10th. set a €65.00 ($77.38) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, September 28th. Berenberg Bank set a €75.00 ($89.29) target price on shares of Gerresheimer and gave the company a buy rating in a report on Friday, December 8th. Finally, JPMorgan Chase & Co. set a €87.70 ($104.40) target price on shares of Gerresheimer and gave the company a buy rating in a report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of Hold and an average target price of €71.20 ($84.76).

Shares of Gerresheimer (ETR:GXI) traded up €0.85 ($1.01) during trading hours on Monday, hitting €73.25 ($87.20). 97,607 shares of the stock were exchanged, compared to its average volume of 110,702. Gerresheimer has a 1-year low of €59.97 ($71.39) and a 1-year high of €78.25 ($93.15). The stock has a market capitalization of $2,300.00 and a PE ratio of 51.95.

ILLEGAL ACTIVITY NOTICE: “Deutsche Bank Analysts Give Gerresheimer (GXI) a €66.00 Price Target” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2018/01/23/deutsche-bank-analysts-give-gerresheimer-gxi-a-66-00-price-target.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.